Clinical trial
Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
NCT00264368 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
- Lead sponsor
- University of Oslo School of Pharmacy
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- December 31, 2005
- Completion date
- June 30, 2007
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute renal failure, cytomegalovirus infections, multi organ failure